LAG3 and esophageal squamous cell carcinoma: Similarly, Zhang et al. could demonstrate that LAG-3 expression in a mixed cohort of patients with esophageal squamous cell carcinoma encompassing all stages (I–IV) was associated with improved survival, whereas the favorable effect of high versus low LAG-3 expression on outcome was restricted to stage I–II cancers [23].